Moderna says construction of its new mRNA vaccine factory in the Montreal area will begin later this year, with production expected to begin by the end of 2024.
The vaccine manufacturer is announcing that it has agreed to purchase land in a biotechnology park in Laval, Que., a northern suburb of Montreal, to serve as the site of its biomanufacturing facility.
